Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-07 @ 12:14 PM
Study NCT ID:
NCT03325556
Status:
COMPLETED
Last Update Posted:
2021-06-21
First Post:
2017-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-18
First Submit QC Date:
None
Study First Post Date:
2017-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-30
Results First Submit QC Date:
None
Results First Post Date:
2021-06-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-06-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-27
Last Update Post Date:
2021-06-21
Last Update Post Date Type:
ACTUAL